Page last updated: 2024-11-03

prazosin and Cardiomyopathy, Chagas

prazosin has been researched along with Cardiomyopathy, Chagas in 2 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pileggi, F1
Bellotti, G1
Galiano, N1
de Moraes, V1
Ramires, JA1
de Mello, CP1
Décourt, LV1
Bergdolt, BA1
Tanowitz, HB1
Wittner, M1
Morris, SA1
Bilezikian, JP1
Moreno, AP1
Spray, DC1

Other Studies

2 other studies available for prazosin and Cardiomyopathy, Chagas

ArticleYear
[Echocardiographic, hemodynamic and clinical effects of prazosin in subjects with severe cardiopathy caused by Chagas disease].
    Cardiology, 1980, Volume: 66 Suppl 2

    Topics: Adult; Chagas Cardiomyopathy; Echocardiography; Heart Failure; Hemodynamics; Humans; Male; Middle Ag

1980
Trypanosoma cruzi: effects of infection on receptor-mediated chronotropy and Ca2+ mobilization in rat cardiac myocytes.
    Experimental parasitology, 1994, Volume: 78, Issue:2

    Topics: Animals; Animals, Newborn; Calcium; Cells, Cultured; Chagas Cardiomyopathy; Guanylyl Imidodiphosphat

1994